What is the market doing?
What the tape says about COLL
Collegium Pharmaceutical, Inc. is −17% over the past year while the S&P 500 is +23%: 39 points behind the market.
−17%
1-year return · S&P 500 +23%
- vs 200-day average
- −29%
vs 200-day average · a clear downtrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- −45%
Below its 52-week high
Details›
- Last close2026-08-26
- $27.50
- 1 monthS&P 500 +3.7%
- −23%
- 1 yearS&P 500 +23%
- −17%
- 5 yearsS&P 500 +87%
- +10%
- vs 50-day average$32.50
- −15%
- 52-week high
- $49.84
- 52-week low
- $25.69
- Annualised volatility
- 42%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$629K
| Year | Return |
|---|---|
| 2026 (year to date) | −41% |
| 2025 | +62% |
| 2024 | −6.9% |
| 2023 | +33% |
| 2022 | +24% |
| 2021 | −6.7% |
| 2020 | −2.7% |
| 2019 | +20% |
| 2018 | −7.0% |
| 2017 | +19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +8.4% |
| Feb | 10 | 5 of 10 | +0.12% |
| Mar | 10 | 5 of 10 | −7.9% |
| Apr | 10 | 2 of 10 | −3.4% |
| May | 10 | 3 of 10 | −3.5% |
| Jun | 10 | 6 of 10 | +6.3% |
| Jul | 11 | 6 of 11 | −1.4% |
| Aug | 11 | 5 of 11 | −3.5% |
| Sep | 10 | 4 of 10 | +10% |
| Oct | 10 | 4 of 10 | −2.5% |
| Nov | 10 | 8 of 10 | +23% |
| Dec | 10 | 5 of 10 | +1.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #13 of 28 by Smart Score